封面
市场调查报告书
商品编码
1193130

电疗市场:按类型、应用、最终用户分类:2021-2031 年全球机遇分析和行业预测

Electrotherapy Market By Type, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3个工作天内

价格

全球电疗市场将在 2021 年达到 9.79 亿美元,在 2031 年达到 16.364 亿美元,从 2022 年到 2031 年的复合年增长率为 5.3%。

电疗使用电流对身体产生治疗效果。 有针对性的电刺激已成为许多物理治疗师治疗慢性疼痛、肌肉骨骼损伤、肌肉无力、神经痛等的有力工具。 电疗是一种温和的非侵入性疗法,通过刺激皮肤表面的神经和肌肉来发挥作用。 电刺激会阻断或干扰身体的疼痛信号,从而缓解疼痛。 释放内啡□(化学信使)以减轻疼痛。 它刺激肌肉组织收缩,减少萎缩,并在体内产生加热效果,以改善血液循环并促进癒合。

电疗市场受到糖尿病人口增加、电疗设备技术进步和运动损伤增加的推动。 糖尿病周围神经病变 (DPN) 是糖尿病最常见且最常引起疼痛的并发症,估计影响 16% 至 33% 的糖尿病患者。 不同类型的电疗用于治疗糖尿病周围神经病变。 此外,根据国际糖尿病联合会的数据,到 2021 年,全球将有大约 5.37 亿成年人患有糖尿病。 糖尿病患者总数预计到 2030 年将增加到 6.43 亿,到 2045 年将增加到 7.83 亿。 因此,预计糖尿病患病率上升将推动对电疗的需求并促进市场增长。 此外,越来越多的电疗设备产品发布和批准也有助于推动市场增长。 例如,2022 年 5 月,医疗设备製造商Abbott实验室宣布美国食品和药物管理局 (FDA) 批准 Proclaim Plus,这是一种新的脊髓刺激系统,可为多个疼痛部位提供量身定制的缓解。。

与其他年龄段的人相比,老年人更容易患骨科疾病、糖尿病和跌倒受伤,因此据说疼痛的患病率会增加。 因此,不断增长的老年人口增加了对电疗治疗慢性疼痛的需求,并且是推动电疗市场增长的一个因素。 世界各国政府也在增加医疗保健支出。 例如,根据医疗保险和医疗补助服务中心的数据,美国医疗保健支出从 2019 年到 2020 年增长了 9.7%,达到 4.1 万亿美元(每人 12,530 美元)。 医疗费用占国内生产总值的比例约为19.7%。 同样,根据英国国家统计局的数据,2020 年英国的医疗保健总支出将占国内生产总值 (GDP) 的 12.8%,高于 2019 年的 10.2%。 此外,据估计,英国约有 30% 的医疗保健支出用于升级医疗保健基础设施,尤其是公共卫生中心(医院)使用的医疗设备。 因此,全球医疗保健支出的这种增长预计将推动电疗应用在治疗各种疾病方面的需求,并推动市场增长。

另一方面,人们对电疗和慢性疼痛治疗□□缺乏认识预计将抑制电疗市场的增长。

内容

第一章介绍

第 2 章执行摘要

第 3 章市场概述

  • 市场定义和范围
  • 主要发现
    • 主要投资领域
  • 波特的五力分析
  • 主要公司的定位
  • 市场动态
    • 司机
    • 约束因素
    • 机会
  • COVID-19 影响分析
  • 专利情况

第 4 章电疗市场:按类型

  • 概览
    • 市场规模和预测
  • 经皮神经电刺激
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测:按地区
    • 市场分析:按国家/地区分类
  • 治疗超声
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测:按地区
    • 市场分析:按国家/地区分类
  • 其他
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测:按地区
    • 市场分析:按国家/地区分类

第 5 章电疗市场:按应用

  • 概览
    • 市场规模和预测
  • 疼痛管理
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测:按地区
    • 市场分析:按国家/地区分类
    • 疼痛管理电疗市场:按类型分类
      • 腰痛市场规模和预测:按地区
      • 颈部疼痛的市场规模和预测:按地区
  • 焦虑和失眠管理
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测:按地区
    • 市场分析:按国家/地区分类
  • 运动医学
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测:按地区
    • 市场分析:按国家/地区分类
  • 其他
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测:按地区
    • 市场分析:按国家/地区分类

第 6 章电疗市场:按最终用户分类

  • 概览
    • 市场规模和预测
  • 医院和诊所
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测:按地区
    • 市场分析:按国家/地区分类
  • 康復中心
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测:按地区
    • 市场分析:按国家/地区分类

第 7 章电疗市场:按地区

  • 概览
    • 市场规模和预测
  • 北美
    • 主要趋势和机会
    • 北美市场规模和预测:按类型
    • 北美市场规模和预测:按应用
      • 北美疼痛管理电疗设备市场:按类型分类
    • 北美市场规模和预测:按最终用户分类
    • 北美市场规模和预测:按国家/地区分类
      • 美国
      • 加拿大
      • 墨西哥
  • 欧洲
    • 主要趋势和机会
    • 欧洲市场规模和预测:按类型
    • 欧洲市场规模和预测:按应用分类
      • 欧洲疼痛管理电疗市场:按类型分类
    • 欧洲市场规模和预测:按最终用户分类
    • 欧洲市场规模和预测:按国家/地区分类
      • 德国
      • 法国
      • 英国
      • 意大利
      • 西班牙
      • 其他欧洲
  • 亚太地区
    • 主要趋势和机会
    • 亚太市场规模和预测:按类型
    • 亚太市场规模和预测:按应用
      • 亚太地区疼痛管理电疗设备市场:按类型分类
    • 亚太市场规模和预测:按最终用户分类
    • 亚太地区的市场规模和预测:按国家/地区分类
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 其他亚太地区
  • 拉美
    • 主要趋势和机会
    • LAMEA 市场规模和预测:按类型
    • LAMEA 市场规模和预测:按应用分类
      • LAMEA 疼痛管理电疗设备市场:按类型分类
    • LAMEA 市场规模和预测:按最终用户分类
    • LAMEA 市场规模和预测:按国家/地区分类
      • 巴西
      • 沙特阿拉伯
      • 南非
      • 其他拉美地区

第八章公司情况

  • 简介
  • 关键成功策略
  • 10 家主要公司的产品映射
  • 比赛仪表板
  • 竞争热图
  • 主要发展

第九章公司简介

  • Abbott Laboratories
  • AliMed
  • Colfax
  • ems physio ltd
  • HMS Medical system
  • Medtronic, Inc.
  • Omron Healthcare
  • Palex Medical SA
  • Zynex Medical
  • Skin Inc.
Product Code: A15398

The global electrotherapy market was valued at $979.0 million in 2021, and is projected to reach $1,636.4 million by 2031, registering a CAGR of 5.3% from 2022 to 2031. Electrotherapy is the use of electrical currents to produce therapeutic effects on the body. It is a powerful tool used by many physiotherapists to treat chronic pain, musculoskeletal injuries, muscle wasting, and nerve pain by using targeted & controlled electrical stimulation. Electrotherapy is a gentle & non-invasive modality that works by stimulating nerves & muscles through the surface of the skin. It sends out electrical impulses that block or interfere with the body's pain signals, leading to reduced pain. It helps to release endorphins (chemical messengers) that naturally decrease pain in the body. It stimulates muscle tissue to contract to reduce atrophy and creates a heating effect within the body which improves circulation & stimulates healing.

The electrotherapy market is driven by an increase in the prevalence of diabetes, advancement in technology in electrotherapy systems, and a rise in number of sports injuries. Diabetic peripheral neuropathy (DPN) is the most common complication of diabetes and is often associated with pain, affecting 16% to 33% of diabetes patients. Different types of electrotherapies are used to treat diabetic peripheral neuropathy. Further, according to the International Diabetes Federation, in 2021, approximately 537 million adult population across the globe suffered from diabetes. The total number of people suffering from diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Thus, rise in the prevalence of diabetes is anticipated to drive the demand for electrotherapy, thereby strengthening the market growth. In addition, rise in number of product launches & approvals for electrotherapy devices contributes to driving the market growth. For instance, in May 2022, Abbott Laboratories, a medical device manufacturing company, announced the approval of the U.S. Food and Drug Administration (FDA) for its new Proclaim Plus spinal cord stimulation system, which provides tailored relief to multiple pain areas.

The geriatric population is more susceptible to orthopedic disorders, diabetes, and fall injuries as compared to other age groups, which results in rise in the prevalence of pain. Thus, rise in geriatric population increases the demand for electrotherapy for the treatment of chronic pain which contributes to drive the growth of electrotherapy market. In addition, governments globally have increased the expenditure on the healthcare sector.  For instance, according to the Centers for Medicare & Medicaid Services, U.S. health care spending grew by 9.7% from 2019 to 2020 reaching $4.1 trillion ($12,530 per person).   As a share of the nation's Gross Domestic Product, healthcare spending accounted for around 19.7 %. Similarly, as per the Office for National Statistics, total healthcare expenditure in the UK accounted for 12.8% of the gross domestic product (GDP) in 2020, compared to 10.2% in 2019. Furthermore, it was estimated that approximately 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure in the UK, especially medical equipment used at public health centers (hospitals). Hence, this rise in healthcare expenditure across the globe is expected to fuel the demand for electrotherapy applications in different disease treatments, thereby boosting market growth.

On the other hand, the lack of awareness among people regarding electrotherapy and the different options available for the treatment of chronic pain is anticipated to restrain the growth of the electrotherapy market.  

The global electrotherapy market is segmented on the basis of type, application, end-user, and region. On the basis of type, the market is segmented into transcutaneous electrical nerve stimulation, therapeutic ultrasound, and others. Other segments include electrical muscle stimulation, and interferential current (IC) therapy. By application, the market is classified into pain management, anxiety & insomnia management, sports medicine, and others. The pain management segment is divided into back pain and neck pain. Other segments include veterinary pain management, aesthetic, face lifting & toning. As per end user, the market is bifurcated into hospitals & clinics, and rehabilitation centers. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global electrotherapy market include Abbott, AliMed, Colfax, EMS Physio Ltd, HMS Medical system, Medtronic, OMRON Healthcare, Palex Medical, Skin Inc., and Zynex Medical.                        

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the electrotherapy market analysis from 2021 to 2031 to identify the prevailing electrotherapy market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the electrotherapy market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global electrotherapy market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Transcutaneous electrical nerve stimulation
  • Therapeutic ultrasound
  • Others

By Application

  • Pain management
    • Type
    • Back pain
    • Neck pain
  • Anxiety and Insomnia Management
  • Sports Medicine
  • Others

By End User

  • Hospitals and clinics
  • Rehabilitation Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest Of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest Of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest Of LAMEA
  • Key Market Players
    • Abbott Laboratories
    • AliMed
    • Colfax
    • ems physio ltd
    • HMS Medical system
    • Medtronic, Inc.
    • Omron Healthcare
    • Palex Medical SA
    • Zynex Medical
    • Skin Inc.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market
  • 3.7.Patent Landscape

CHAPTER 4: ELECTROTHERAPY MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Transcutaneous electrical nerve stimulation
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Therapeutic ultrasound
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Others
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country

CHAPTER 5: ELECTROTHERAPY MARKET, BY APPLICATION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Pain management
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
    • 5.2.4 Pain management Electrotherapy Market by Type
      • 5.2.4.1 Back pain Market size and forecast, by region
      • 5.2.4.2 Neck pain Market size and forecast, by region
  • 5.3 Anxiety and Insomnia Management
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Sports Medicine
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country
  • 5.5 Others
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market analysis by country

CHAPTER 6: ELECTROTHERAPY MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospitals and clinics
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Rehabilitation Centers
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country

CHAPTER 7: ELECTROTHERAPY MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Type
    • 7.2.3 North America Market size and forecast, by Application
      • 7.2.3.1 North America Pain management Electrotherapy Market by Type
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Type
      • 7.2.5.1.2 Market size and forecast, by Application
      • 7.2.5.1.3 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Type
      • 7.2.5.2.2 Market size and forecast, by Application
      • 7.2.5.2.3 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Type
      • 7.2.5.3.2 Market size and forecast, by Application
      • 7.2.5.3.3 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Type
    • 7.3.3 Europe Market size and forecast, by Application
      • 7.3.3.1 Europe Pain management Electrotherapy Market by Type
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Type
      • 7.3.5.1.2 Market size and forecast, by Application
      • 7.3.5.1.3 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Type
      • 7.3.5.2.2 Market size and forecast, by Application
      • 7.3.5.2.3 Market size and forecast, by End User
      • 7.3.5.3 UK
      • 7.3.5.3.1 Market size and forecast, by Type
      • 7.3.5.3.2 Market size and forecast, by Application
      • 7.3.5.3.3 Market size and forecast, by End User
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Market size and forecast, by Type
      • 7.3.5.4.2 Market size and forecast, by Application
      • 7.3.5.4.3 Market size and forecast, by End User
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Type
      • 7.3.5.5.2 Market size and forecast, by Application
      • 7.3.5.5.3 Market size and forecast, by End User
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Market size and forecast, by Type
      • 7.3.5.6.2 Market size and forecast, by Application
      • 7.3.5.6.3 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Application
      • 7.4.3.1 Asia-Pacific Pain management Electrotherapy Market by Type
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 China
      • 7.4.5.1.1 Market size and forecast, by Type
      • 7.4.5.1.2 Market size and forecast, by Application
      • 7.4.5.1.3 Market size and forecast, by End User
      • 7.4.5.2 Japan
      • 7.4.5.2.1 Market size and forecast, by Type
      • 7.4.5.2.2 Market size and forecast, by Application
      • 7.4.5.2.3 Market size and forecast, by End User
      • 7.4.5.3 India
      • 7.4.5.3.1 Market size and forecast, by Type
      • 7.4.5.3.2 Market size and forecast, by Application
      • 7.4.5.3.3 Market size and forecast, by End User
      • 7.4.5.4 Australia
      • 7.4.5.4.1 Market size and forecast, by Type
      • 7.4.5.4.2 Market size and forecast, by Application
      • 7.4.5.4.3 Market size and forecast, by End User
      • 7.4.5.5 Rest of Asia-Pacific
      • 7.4.5.5.1 Market size and forecast, by Type
      • 7.4.5.5.2 Market size and forecast, by Application
      • 7.4.5.5.3 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Type
    • 7.5.3 LAMEA Market size and forecast, by Application
      • 7.5.3.1 LAMEA Pain management Electrotherapy Market by Type
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Type
      • 7.5.5.1.2 Market size and forecast, by Application
      • 7.5.5.1.3 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Type
      • 7.5.5.2.2 Market size and forecast, by Application
      • 7.5.5.2.3 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Market size and forecast, by Type
      • 7.5.5.3.2 Market size and forecast, by Application
      • 7.5.5.3.3 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Type
      • 7.5.5.4.2 Market size and forecast, by Application
      • 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Abbott Laboratories
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 AliMed
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Colfax
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 ems physio ltd
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 HMS Medical system
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Medtronic, Inc.
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Omron Healthcare
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Palex Medical SA
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Zynex Medical
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Skin Inc.
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 2. ELECTROTHERAPY MARKET, FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. ELECTROTHERAPY MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. ELECTROTHERAPY MARKET, FOR THERAPEUTIC ULTRASOUND, BY REGION, 2021-2031 ($MILLION)
  • TABLE 5. ELECTROTHERAPY MARKET FOR THERAPEUTIC ULTRASOUND, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 6. ELECTROTHERAPY MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 7. ELECTROTHERAPY MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 8. GLOBAL ELECTROTHERAPY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 9. ELECTROTHERAPY MARKET, FOR PAIN MANAGEMENT, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. ELECTROTHERAPY MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 11. GLOBAL PAIN MANAGEMENT ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 12. ELECTROTHERAPY MARKET, FOR BACK PAIN, BY REGION, 2021-2031 ($MILLION)
  • TABLE 13. ELECTROTHERAPY MARKET, FOR NECK PAIN, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. ELECTROTHERAPY MARKET, FOR ANXIETY AND INSOMNIA MANAGEMENT, BY REGION, 2021-2031 ($MILLION)
  • TABLE 15. ELECTROTHERAPY MARKET FOR ANXIETY AND INSOMNIA MANAGEMENT, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 16. ELECTROTHERAPY MARKET, FOR SPORTS MEDICINE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 17. ELECTROTHERAPY MARKET FOR SPORTS MEDICINE, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 18. ELECTROTHERAPY MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 19. ELECTROTHERAPY MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 20. GLOBAL ELECTROTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 21. ELECTROTHERAPY MARKET, FOR HOSPITALS AND CLINICS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 22. ELECTROTHERAPY MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 23. ELECTROTHERAPY MARKET, FOR REHABILITATION CENTERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 24. ELECTROTHERAPY MARKET FOR REHABILITATION CENTERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 25. ELECTROTHERAPY MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 26. NORTH AMERICA ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 27. NORTH AMERICA ELECTROTHERAPY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 28. NORTH AMERICA PAIN MANAGEMENT ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 29. NORTH AMERICA ELECTROTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 30. NORTH AMERICA ELECTROTHERAPY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 31. U.S. ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 32. U.S. ELECTROTHERAPY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 33. U.S. ELECTROTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 34. CANADA ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 35. CANADA ELECTROTHERAPY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 36. CANADA ELECTROTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 37. MEXICO ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 38. MEXICO ELECTROTHERAPY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 39. MEXICO ELECTROTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 40. EUROPE ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 41. EUROPE ELECTROTHERAPY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 42. EUROPE PAIN MANAGEMENT ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 43. EUROPE ELECTROTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 44. EUROPE ELECTROTHERAPY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 45. GERMANY ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 46. GERMANY ELECTROTHERAPY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 47. GERMANY ELECTROTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 48. FRANCE ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 49. FRANCE ELECTROTHERAPY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 50. FRANCE ELECTROTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 51. UK ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 52. UK ELECTROTHERAPY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 53. UK ELECTROTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 54. ITALY ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 55. ITALY ELECTROTHERAPY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 56. ITALY ELECTROTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 57. SPAIN ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 58. SPAIN ELECTROTHERAPY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 59. SPAIN ELECTROTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 60. REST OF EUROPE ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 61. REST OF EUROPE ELECTROTHERAPY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 62. REST OF EUROPE ELECTROTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 63. ASIA-PACIFIC ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 64. ASIA-PACIFIC ELECTROTHERAPY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 65. ASIA-PACIFIC PAIN MANAGEMENT ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 66. ASIA-PACIFIC ELECTROTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 67. ASIA-PACIFIC ELECTROTHERAPY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 68. CHINA ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 69. CHINA ELECTROTHERAPY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 70. CHINA ELECTROTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 71. JAPAN ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 72. JAPAN ELECTROTHERAPY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 73. JAPAN ELECTROTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 74. INDIA ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 75. INDIA ELECTROTHERAPY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 76. INDIA ELECTROTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 77. AUSTRALIA ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 78. AUSTRALIA ELECTROTHERAPY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 79. AUSTRALIA ELECTROTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 80. REST OF ASIA-PACIFIC ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 81. REST OF ASIA-PACIFIC ELECTROTHERAPY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 82. REST OF ASIA-PACIFIC ELECTROTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 83. LAMEA ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 84. LAMEA ELECTROTHERAPY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 85. LAMEA PAIN MANAGEMENT ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 86. LAMEA ELECTROTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 87. LAMEA ELECTROTHERAPY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 88. BRAZIL ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 89. BRAZIL ELECTROTHERAPY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 90. BRAZIL ELECTROTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 91. SAUDI ARABIA ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 92. SAUDI ARABIA ELECTROTHERAPY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 93. SAUDI ARABIA ELECTROTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 94. SOUTH AFRICA ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 95. SOUTH AFRICA ELECTROTHERAPY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 96. SOUTH AFRICA ELECTROTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 97. REST OF LAMEA ELECTROTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 98. REST OF LAMEA ELECTROTHERAPY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 99. REST OF LAMEA ELECTROTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 100.ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 101.ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 102.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 103.ABBOTT LABORATORIES: NET SALES,
  • TABLE 104.ABBOTT LABORATORIES: KEY STRATERGIES
  • TABLE 105.ALIMED: COMPANY SNAPSHOT
  • TABLE 106.ALIMED: OPERATING SEGMENTS
  • TABLE 107.ALIMED: PRODUCT PORTFOLIO
  • TABLE 108.ALIMED: NET SALES,
  • TABLE 109.ALIMED: KEY STRATERGIES
  • TABLE 110.COLFAX: COMPANY SNAPSHOT
  • TABLE 111.COLFAX: OPERATING SEGMENTS
  • TABLE 112.COLFAX: PRODUCT PORTFOLIO
  • TABLE 113.COLFAX: NET SALES,
  • TABLE 114.COLFAX: KEY STRATERGIES
  • TABLE 115.EMS PHYSIO LTD: COMPANY SNAPSHOT
  • TABLE 116.EMS PHYSIO LTD: OPERATING SEGMENTS
  • TABLE 117.EMS PHYSIO LTD: PRODUCT PORTFOLIO
  • TABLE 118.EMS PHYSIO LTD: NET SALES,
  • TABLE 119.EMS PHYSIO LTD: KEY STRATERGIES
  • TABLE 120.HMS MEDICAL SYSTEM: COMPANY SNAPSHOT
  • TABLE 121.HMS MEDICAL SYSTEM: OPERATING SEGMENTS
  • TABLE 122.HMS MEDICAL SYSTEM: PRODUCT PORTFOLIO
  • TABLE 123.HMS MEDICAL SYSTEM: NET SALES,
  • TABLE 124.HMS MEDICAL SYSTEM: KEY STRATERGIES
  • TABLE 125.MEDTRONIC, INC.: COMPANY SNAPSHOT
  • TABLE 126.MEDTRONIC, INC.: OPERATING SEGMENTS
  • TABLE 127.MEDTRONIC, INC.: PRODUCT PORTFOLIO
  • TABLE 128.MEDTRONIC, INC.: NET SALES,
  • TABLE 129.MEDTRONIC, INC.: KEY STRATERGIES
  • TABLE 130.OMRON HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 131.OMRON HEALTHCARE: OPERATING SEGMENTS
  • TABLE 132.OMRON HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 133.OMRON HEALTHCARE: NET SALES,
  • TABLE 134.OMRON HEALTHCARE: KEY STRATERGIES
  • TABLE 135.PALEX MEDICAL SA: COMPANY SNAPSHOT
  • TABLE 136.PALEX MEDICAL SA: OPERATING SEGMENTS
  • TABLE 137.PALEX MEDICAL SA: PRODUCT PORTFOLIO
  • TABLE 138.PALEX MEDICAL SA: NET SALES,
  • TABLE 139.PALEX MEDICAL SA: KEY STRATERGIES
  • TABLE 140.ZYNEX MEDICAL: COMPANY SNAPSHOT
  • TABLE 141.ZYNEX MEDICAL: OPERATING SEGMENTS
  • TABLE 142.ZYNEX MEDICAL: PRODUCT PORTFOLIO
  • TABLE 143.ZYNEX MEDICAL: NET SALES,
  • TABLE 144.ZYNEX MEDICAL: KEY STRATERGIES
  • TABLE 145.SKIN INC.: COMPANY SNAPSHOT
  • TABLE 146.SKIN INC.: OPERATING SEGMENTS
  • TABLE 147.SKIN INC.: PRODUCT PORTFOLIO
  • TABLE 148.SKIN INC.: NET SALES,
  • TABLE 149.SKIN INC.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.ELECTROTHERAPY MARKET SEGMENTATION
  • FIGURE 2.ELECTROTHERAPY MARKET,2021-2031
  • FIGURE 3.ELECTROTHERAPY MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.ELECTROTHERAPY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.PATENT ANALYSIS BY COMPANY
  • FIGURE 13.PATENT ANALYSIS BY COUNTRY
  • FIGURE 14.ELECTROTHERAPY MARKET,BY TYPE,2021(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION ELECTROTHERAPY MARKET,2021-2031(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF THERAPEUTIC ULTRASOUND ELECTROTHERAPY MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF OTHERS ELECTROTHERAPY MARKET,2021-2031(%)
  • FIGURE 18.ELECTROTHERAPY MARKET,BY APPLICATION,2021(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF PAIN MANAGEMENT ELECTROTHERAPY MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF ANXIETY AND INSOMNIA MANAGEMENT ELECTROTHERAPY MARKET,2021-2031(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF SPORTS MEDICINE ELECTROTHERAPY MARKET,2021-2031(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF OTHERS ELECTROTHERAPY MARKET,2021-2031(%)
  • FIGURE 23.ELECTROTHERAPY MARKET,BY END USER,2021(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS ELECTROTHERAPY MARKET,2021-2031(%)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF REHABILITATION CENTERS ELECTROTHERAPY MARKET,2021-2031(%)
  • FIGURE 26.ELECTROTHERAPY MARKET BY REGION,2021
  • FIGURE 27.U.S. ELECTROTHERAPY MARKET,2021-2031($MILLION)
  • FIGURE 28.CANADA ELECTROTHERAPY MARKET,2021-2031($MILLION)
  • FIGURE 29.MEXICO ELECTROTHERAPY MARKET,2021-2031($MILLION)
  • FIGURE 30.GERMANY ELECTROTHERAPY MARKET,2021-2031($MILLION)
  • FIGURE 31.FRANCE ELECTROTHERAPY MARKET,2021-2031($MILLION)
  • FIGURE 32.UK ELECTROTHERAPY MARKET,2021-2031($MILLION)
  • FIGURE 33.ITALY ELECTROTHERAPY MARKET,2021-2031($MILLION)
  • FIGURE 34.SPAIN ELECTROTHERAPY MARKET,2021-2031($MILLION)
  • FIGURE 35.REST OF EUROPE ELECTROTHERAPY MARKET,2021-2031($MILLION)
  • FIGURE 36.CHINA ELECTROTHERAPY MARKET,2021-2031($MILLION)
  • FIGURE 37.JAPAN ELECTROTHERAPY MARKET,2021-2031($MILLION)
  • FIGURE 38.INDIA ELECTROTHERAPY MARKET,2021-2031($MILLION)
  • FIGURE 39.AUSTRALIA ELECTROTHERAPY MARKET,2021-2031($MILLION)
  • FIGURE 40.REST OF ASIA-PACIFIC ELECTROTHERAPY MARKET,2021-2031($MILLION)
  • FIGURE 41.BRAZIL ELECTROTHERAPY MARKET,2021-2031($MILLION)
  • FIGURE 42.SAUDI ARABIA ELECTROTHERAPY MARKET,2021-2031($MILLION)
  • FIGURE 43.SOUTH AFRICA ELECTROTHERAPY MARKET,2021-2031($MILLION)
  • FIGURE 44.REST OF LAMEA ELECTROTHERAPY MARKET,2021-2031($MILLION)
  • FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 49.COMPETITIVE DASHBOARD
  • FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 51.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
  • FIGURE 52.ALIMED.: NET SALES ,($MILLION)
  • FIGURE 53.COLFAX.: NET SALES ,($MILLION)
  • FIGURE 54.EMS PHYSIO LTD.: NET SALES ,($MILLION)
  • FIGURE 55.HMS MEDICAL SYSTEM.: NET SALES ,($MILLION)
  • FIGURE 56.MEDTRONIC, INC..: NET SALES ,($MILLION)
  • FIGURE 57.OMRON HEALTHCARE.: NET SALES ,($MILLION)
  • FIGURE 58.PALEX MEDICAL SA.: NET SALES ,($MILLION)
  • FIGURE 59.ZYNEX MEDICAL.: NET SALES ,($MILLION)
  • FIGURE 60.SKIN INC..: NET SALES ,($MILLION)